Dosing-Time-Dependent Variation in Biliary Excretion of Flomoxef in Rats

References

• Bailey D. G., Paul H., Johnson G. E. Pentobarbital inhibits the biliary excretion of organic acids: a study with succinylsulfathiazole in the rat. Can. J. Pharmacol. 1975; 53(3)470–474
   Google Scholar
• Belanger P. M., Bruguerolle B., Labrecque G. Rhythms in pharmacokinetics: absorption, distribution, metabolism, and excretion. Physiology and Pharmacology of Biological Rhythms, P. H. Redfern, B. Lemmer. Springer, BerlinGermany 1997; 177–204
   Google Scholar
• Bleyzac N., Allard-Latour B., Laffont A., Mouret J., Jelliffe R., Maire P. Diurnal changes in the pharmacokinetic behavior of amikacin. Ther. Drug Monit. 2000; 22(3)307–312
   PubMedGoogle Scholar
• Cooke W. J., Cooke L. Effects of anesthetic agents on the biliary excretion of iopanoate in the rat. Drug. Metab. Dispos. 1977; 5(4)377–385
   PubMedGoogle Scholar
• Cure H., Chevalier V., Pezet D., Bousquet J., Focan C., Levi F., Garufi C., Chipponi J., Chollet P. Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer. Anticancer Res. 2000; 20(6C)4649–4654
   PubMedGoogle Scholar
• Dickson C. J., Schwartzman M. S., Bertino J. S. Factors affecting aminoglycoside disposition: effects of circadian rhythm and dietary protein intake on gentamicin pharmacokinetics. Clin. Pharmacol. Ther. 1986; 39(3)325–328
   PubMedGoogle Scholar
• Dijkstra M., Kuipers F., Smit E. P., deVries J. J., Havinga R., Vonk R. J. Biliary secretion of trace elements and minerals in the rat. Effect of bile flow variation and diurnal rhythms. J. Hepatol. 1991; 13(1)112–119
   PubMedGoogle Scholar
• Giacchetti S. Chronotherapy of colorectal cancer. Chronobiol. Int. 2002; 19(1)207–219
   PubMed Web of Science ®Google Scholar
• Hishikawa S., Kobayashi E., Sugimoto K., Miyata M., Fujimura A. Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage. Br. J. Clin. Pharmacol. 2001; 52(1)65–68
   PubMedGoogle Scholar
• Ho K.-J. Circadian rhythmic hepatic biliary flow, constituents, concentrations and excretory rates in patients after cholecystectomy. Chronobiologia 1994; 21(3–4)283–292
   PubMedGoogle Scholar
• Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 1997; 272(1 Pt 1)G16–G22
   Google Scholar
• Jones R. N., Pfaller M. A., Cormican M. G. Infectious diseases (bacterial and fungal): principles and practice of antimicrobial therapy. Avery's Drug Treatment, T. M. Speight, N. H. G. Holford. 4th ed., ADIS International, AucklandNew Zealand 1997; 1455 pp
   Google Scholar
• Kobayashi M., Wood P. A., Hrushesky W. J. M. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol. Int. 2002; 19(1)237–251
   PubMed Web of Science ®Google Scholar
• Konaka R., Hashimoto H., Nishimura R., Hirauchi K. Assays of 6315-S (flomoxef) and its metabolites in body fluids by high-performance liquid chromatography. Chemotherapy 1987; 35(1)137–144
   Google Scholar
• Kurtz W., Leuschner U., Schneider S., Classen M. Diurnal rhythm of bile lipid composition after cholecystectomy and papillotomy. Postpapillotomy biliary lithogenicity. Scand. J. Gastroentenol. 1985; 20(8)1001–1006
   PubMed Web of Science ®Google Scholar
• Lemmer B., Portaluppi F. Chronopharmacology of cardiovascular diseases. Physiology and Pharmacology of Biological Rhythms, P. H. Redfern, B. Lemmer. Springer, BerlinGermany 1997; 251–297
   Google Scholar
• Levi F. Chronopharmacology of anticancer agents. Physiology and Pharmacology of Biological Rhythms, P. H. Redfern, B. Lemmer. Springer, BerlinGermany 1997; 299–331
   Google Scholar
• Mesnard-Ricci B., White C. A. Chronokinetics of active biliary ampicillin secretion in rats. Chronobiol. Int. 1998; 15(4)309–321
   PubMed Web of Science ®Google Scholar
• Milano G., Chamorey A. L. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol. Int. 2002; 19(1)177–189
   PubMed Web of Science ®Google Scholar
• Mizojiri K., Okabe H., Tanaka H., Sugeno K. Disposition of 6315-S (flomoxef) in rats (I). Chemotherapy 1987; 35(1)176–186
   Google Scholar
• Nakano A., Tietz P. S., LaRusso N. F. Circadian rhythms of biliary protein and lipid excretion in rats. Am. J. Physiol. 1990; 258(5 Pt 1)G653–G659
   Google Scholar
• Pardue R. L., White C. A. Chronokinetics of liposomal encapsulated ampicillin in fasting and nonfasting rats. J. Pharm. Sci. 1996; 85(3)309–312
   PubMed Web of Science ®Google Scholar
• Sathirakul K., Suzuki H., Yasuda K., Hanano M., Tagaya O., Horie T., Sugiyama Y. Kinetic analysis of hepatobiliary transport of organic anions in Eisai Hyperbilirubinemic mutant rats. J. Pharmacol. Exp. Ther. 1993; 265(3)1301–1312
   PubMedGoogle Scholar
• Sathirakul K., Suzuki H., Yamada T., Hamano M., Sugiyama Y. Multiple transport systems for organic anions across the bile canalicular membrane. J. Pharmacol. Exp. Ther. 1994; 268(1)65–73
   PubMedGoogle Scholar
• Shimamura H., Suzuki H., Hanano M., Suzuki A., Tagaya O., Horie T., Sugiyama Y. Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. J. Pharmacol. Exp. Ther. 1994; 271(1)370–378
   PubMedGoogle Scholar
• Shyu W. C., Gleason C. R., Barbhaiya R. H. Effects of time of administration and posture on the pharmacokinetics of cefprozil. Clin. Pharmacokinet. 1993; 25(3)237–242
   PubMedGoogle Scholar
• Sugano S., Yamamoto K., Sasao K., Ishii K., Watanabe M., Tanikawa K. Daily variation of azygos and portal blood flow and the effect of propranolol administration once an evening in cirrhotics. J. Hepatol. 2001; 34(1)26–31
   PubMedGoogle Scholar
• Yoshiyama Y., Kobayashi T., Tomonaga F. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J. Antibiot. 1992; 45(5)806–808
   PubMed Web of Science ®Google Scholar
• Yoshiyama Y., Nishikawa S., Sugiyama T., Kobayashi T., Shimada H., Tomonaga F., Ohdo S., Ogawa N., Nakano S. Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob. Agents Chemother. 1993; 37(9)2042–2043
   PubMed Web of Science ®Google Scholar